3rd advanced cancer patient responds fabulously to NCIM treatment approach

February-March 2012: A Mexican national, age 58, with advanced prostate cancer that had spread to his liver and bones (femur and others) was treated using the core NCIM approach. He had had no prior conventional cancer care such as chemotherapy or radiotherapy. At the time of his initial infusion of donor granulocytes his PSA level was almost 1000 and he was very thin, pale, was jaundiced, and could not sit on a sofa comfortable due to the massive size of his tumor-laden prostate gland. In the 2 months since his series of donor granulocytes treatments his PSA has plummeted to 47, his jaundice is gone, and the tumors throughout his body are shrinking very rapidly.

Advertisements

About Nova Cells Institute of Mexico (NCIM)

Nova Cells Institute of Mexico (NCIM), please see our "About" page for full information
This entry was posted in CANCER. Bookmark the permalink.